November 3, 2016
Positive outcome of Mereo’s phase 1 study of acute exacerbations of COPD drug
Mereo reports positive outcome of its phase 1 study of acute exacerbations of COPD drug
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
November 3, 2016
Strides, Mylan settle Regulatory and General Claims on Agila transaction, Strides gets $30M
Strides and Mylan have agree to settle Regulatory and General Claims on Agila transaction.
November 2, 2016
Eli Lilly, Incyte’s rheumatoid arthritis drug studies show positive effect
Eli Lilly and Company and Incyte Corporation have announced on Wednesday that new data from RA-BEACON – a pivotal phase 3 study…
November 2, 2016
Allergan announces $10 B accelerated share repurchase, initiation of cash dividend in 2017
Allergan has completed its initial $5 billion in share repurchases under its previously announced share repurchase program…
November 2, 2016
GE Healthcare, Valneva join forces to create cell culture medium for vaccine
GE Healthcare and Valneva have joined forces to create cell culture medium for vaccine
November 2, 2016
Abzena, Gilead drop Chron Disease drug after Phase II study
Abzena has issued a statement in which it notes that during the conference call to accompany Gilead Sciences Inc.’s (‘Gilead’) announcement of third quarter
November 2, 2016
Targovax CEO steps down, current CFO takes the role
Targovax CEO has stepped down, current CFO takes the role
November 2, 2016
European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech
European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech
November 2, 2016
India’s Ajanta gets green light for its high blood pressure generic
Ajanta Pharma has gotten US FDA’s approval to launch its high blood pressure tablets Amlodipine
November 2, 2016
Shire doubles third quarter revenues, operates with net loss in Q3
Shire doubles third quarter revenues, operates with net loss in Q3